youtube_live
Q1 2027 earnings • in 2 days
See detailschevron_right
LRCX:NASDAQ
Lam Research Corp
$272.20
arrow_upward
+3.13%(+8.26) 1D
$273.01
arrow_upward
+0.30% (+0.81)bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LRCX...
Open
$275.16
High
$279.92
Low
$271.87
Mkt. cap
340.64B
Avg. vol.
9.16M
Volume
10.40M
Dividend
0.48%
Quarterly dividend
$0.33
Ex-dividend date
Sep 23, 2026
P/E ratio
47.25
52-wk high
$438.50
52-wk low
$135.50
EPS
$5.76
Beta
1.81
Shares outstanding
1.25B
No. of employees
23K
Open
$275.16
High
$279.92
Low
$271.87
Mkt. cap
340.64B
Avg. vol.
9.16M
Volume
10.40M
Dividend
0.48%
Quarterly dividend
$0.33
Ex-dividend date
Sep 23, 2026
P/E ratio
47.25
52-wk high
$438.50
52-wk low
$135.50
EPS
$5.76
Beta
1.81
Shares outstanding
1.25B
No. of employees
23K
News stories
From web sources and news partners
Simply Wall Street
·
34 minutes ago
Is Earnings Beat Altering The Investment Case For Lam Research Stock (LRCX)?
Yahoo Finance
·
2 hours ago
Applied Materials, Lam Research, Marvell Technology, Micron, and Semtech Shares Skyrocket, What You Need To Know
MarketWatch
·
3 hours ago
Lam Research Corp. stock outperforms competitors on strong trading day
TradingView
·
4 hours ago
Lam Research Corporation expected to post earnings of $2.18 a share - Earnings Preview
Profile
Lam Research Corporation is an American supplier of wafer-fabrication equipment and related services to the semiconductor industry. Its products are used primarily in front-end wafer processing, which involves the steps that create the active components of semiconductor devices and their wiring. The company also builds equipment for back-end wafer-level packaging and for related manufacturing markets such as for microelectromechanical systems.
Lam Research was founded in 1980 by David K. Lam and is headquartered in Fremont, California. As of 2023, it was the third largest manufacturer in the Bay Area, after Tesla and Intuitive Surgical. Wikipedia
About Lam Research Corp
Analyst ratings
Based on 24 analysts giving stock ratings to LRCX in the past 3 months
Strong buy
Buy
21
Hold
3
Sell
0
12-month forecast
Based on 24 Wall Street analysts offering 12 month price targets for LRCX in the last 3 months.
Highest
Current $272.20
$700.00 (+157.16%)
Average
$399.86 (+46.90%)
Lowest
$275.00 (+1.03%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Melissa Weathers Deutsche Bank | Buy | Maintained | $375.00 | +37.8% | 10/19/2026 |
Craig Ellis B. Riley Securities | Buy | Reiterated | $338.00 | +24.2% | 10/19/2026 |
C J Muse Cantor Fitzgerald | Buy | Reiterated | $500.00 | +83.7% | 10/17/2026 |
Timothy Arcuri UBS | Buy | Maintained | $425.00 | +56.1% | 10/12/2026 |
Ling Lee Keng DBS | Buy | Maintained | $416.00 | +52.8% | 10/08/2026 |
Shane Brett CFA Morgan Stanley | Buy | Reiterated | $385.00 | +41.4% | 10/05/2026 |
Stacy Rasgon Bernstein | Buy | Reiterated | $385.00 | +41.4% | 09/22/2026 |
Vijay Rakesh Mizuho Securities | Buy | Reiterated | $365.00 | +34.1% | 09/21/2026 |
Mehdi Hosseini Susquehanna | Buy | Reiterated | $475.00 | +74.5% | 09/12/2026 |
Tammy Qiu Berenberg Bank | Buy | Maintained | $420.00 | +54.3% | 09/08/2026 |
Unknown Analyst Berenberg Bank | Buy | Maintained | $420.00 | +54.3% | 09/08/2026 |
Atif Malik Citi | Buy | Maintained | $450.00 | +65.3% | 08/24/2026 |
Krish Sankar TD Cowen | Buy | Reiterated | $700.00 | +157.2% | 08/14/2026 |
Harlan Sur J.P. Morgan | Buy | Maintained | $340.00 | +24.9% | 08/04/2026 |
Vivek Arya Bank of America Securities | Buy | Maintained | - | - | 08/04/2026 |
Mark Lipacis Evercore ISI | Buy | Maintained | $275.00 | +1% | 07/30/2026 |
Edward Yang Oppenheimer | Buy | Maintained | $400.00 | +47% | 07/30/2026 |
Charles Shi Needham | Buy | Reiterated | $390.00 | +43.3% | 07/30/2026 |
Brian Chin Stifel Nicolaus | Buy | Reiterated | $425.00 | +56.1% | 07/30/2026 |
Srini Pajjuri RBC Capital | Buy | Reiterated | $380.00 | +39.6% | 07/30/2026 |
Joseph Quatrochi Wells Fargo | Buy | Maintained | $350.00 | +28.6% | 07/29/2026 |
Steve Barger KeyBanc | Hold | Maintained | - | - | 07/30/2026 |
Thomas O'Malley Barclays | Hold | Maintained | $335.00 | +23.1% | 07/30/2026 |
Blayne Curtis Jefferies | Buy | Maintained | $335.00 | +23.1% | 07/30/2026 |
Adithya Metuku HSBC | Hold | Maintained | $333.00 | +22.3% | 07/27/2026 |
David Dai CFA Bernstein | Buy | Maintained | $340.00 | +24.9% | 07/13/2026 |
James Schneider Goldman Sachs | Buy | Maintained | $380.00 | +39.6% | 07/05/2026 |
Jay Goldberg Seaport Global | Buy | Maintained | $300.00 | +10.2% | 05/10/2026 |
Jim Kelleher Argus Research | Buy | Maintained | $300.00 | +10.2% | 04/24/2026 |
Aaron Rakers Wells Fargo | Buy | Maintained | $320.00 | +17.6% | 04/23/2026 |
Stephan Lingnau Erste Group | Hold | Downgraded | - | - | 04/01/2026 |
Kinngai Chan Summit Insights Group | Buy | Upgraded | - | - | 01/28/2026 |
Next call in 44:34:00
Wed, Oct 21, 11:00 PM
Fiscal period
Q1 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $2.18
Revenue / Est. (USD)
- / 8.14B
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 5.32B | 5.34B | 5.84B | 6.72B |
Cost of goods sold | 2.64B | 2.69B | 2.93B | 3.24B |
Cost of revenue | 2.64B | 2.69B | 2.93B | 3.24B |
Research and development expenses | 576.45M | 573.30M | 583.20M | 642.92M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 279.34M | 267.65M | 280.31M | 322.33M |
Operating expense | 855.79M | 840.96M | 863.51M | 965.25M |
Total operating expenses | 3.50B | 3.53B | 3.79B | 4.21B |
Operating income | 1.83B | 1.81B | 2.05B | 2.51B |
Other non operating income | 14.15M | 22.16M | -37.72M | 54.86M |
EBT including unusual items | 1.86B | 1.84B | 2.01B | 2.56B |
EBT excluding unusual items | 1.86B | 1.84B | 2.01B | 2.56B |
Income tax expense | 290.50M | 242.62M | 186.10M | 277.86M |
Effective tax rate | 15.63% | 13.21% | 9.25% | 10.87% |
Other operating expenses | - | - | - | - |
Net income | 1.57B | 1.59B | 1.83B | 2.28B |
Net profit margin | 29.46% | 29.82% | 31.25% | 33.88% |
Earnings per share | 1.26 | 1.27 | 1.47 | 1.82 |
Interest and investment income | 63.93M | 53.16M | 42.64M | 36.46M |
Interest expense | -42.47M | -40.88M | -39.33M | -34.20M |
Net interest expenses | 21.46M | 12.28M | 3.31M | 2.26M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 1.93B | 1.91B | 2.16B | 2.63B |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1